Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726667 | SCV000345914 | uncertain significance | not provided | 2016-09-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000367539 | SCV000722272 | likely benign | not specified | 2017-08-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000726667 | SCV001144911 | benign | not provided | 2018-11-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000367539 | SCV001159935 | likely benign | not specified | 2019-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001521874 | SCV001731293 | benign | Peroxisome biogenesis disorder 9B | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001274737 | SCV001459137 | uncertain significance | Rhizomelic chondrodysplasia punctata type 1 | 2020-01-17 | no assertion criteria provided | clinical testing |